Ponsegromab (PF 06946860) is a selective and effective humanized anti-GDF15 antibody inhibitor with anti-cachexic activity. It binds to GDF15, preventing its interaction with GFRAL and disrupting GDF15/GFRAL mediated signaling. Ponsegromab has potential anticancer activity and can be used to treat cancer patients with cancer anorexia cachexia syndrome.
Purity:
95.00%
CAS Number:
[2368950-15-4]
Target:
TGF-beta/Smad
* VAT and and shipping costs not included. Errors and price changes excepted